Top 10 Holdings of Caligan Partners

7. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)

Caligan Partners’ Equity Stake: $14.98 Million

Number of Hedge Fund Holders: 17

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) is a biotechnology company and one of the top 10 holdings of Caligan Pharmaceuticals. It focuses on discovering and developing small-molecule drugs for treating viral infections and liver diseases.

After dropping by about 80% in 2023, Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) is again on the move in 2024, trying to recoup the losses. It is already up by about 16%. The rally comes on the heels of the company delivering revenues of $17.1 million in Q1 2024 compared to $17.8 million a year ago in the same quarter. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)’s net loss improved to $31.2 million from $37.7 million a year ago.

Among the 920 hedge funds tracked by Insider Monkey’s database, 17 had acquired and held Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) shares as of the end of Q1 2024.